Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inspiratory Capacity and HRCT Comparison of Nebulized Arformoterol (Brovana) vs. Dry-powder Inhaler Salmeterol (Serevent)

NCT01361984 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT01361984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01361984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inspiratory Capacity and HRCT Comparison of Nebulized Arformoterol (Brovana) vs. Dry-powder Inhaler Salmeterol (Serevent)
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2011
Completion date
June 30, 2013
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic bronchitis, chronic obstructive pulmonary disease, copd, emphysema